Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

France's CAC added 121 points ... The forecast was 2.6%. Denmark's Novo Nordisk spiked 7.8% in early trading to DKK803.5. The ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Experienced diabetologist and medical director, Dr. Owen brings to DiogenX over two decades of expertise in diabetes clinical management and drug development, as lead candidate progresses towards ...

(Reuters) - European shares opened higher on Monday with most sectors rising, kicking off a week packed with global economic ...

Novo Nordisk (NVO) has released an update. Novo Nordisk has announced a significant transaction under its 2024 share repurchase program, ...